Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.09, $0.05 better than the analyst estimate of $2.04. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2016 EPS of $7.80-$7.95, versus the consensus of $7.81.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.